• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用英国医疗记录数据识别未来哮喘发作的风险:呼吸有效性研究组的一项倡议。

Identifying Risk of Future Asthma Attacks Using UK Medical Record Data: A Respiratory Effectiveness Group Initiative.

机构信息

Clinical Sciences, Liverpool School of Tropical Medicine, and Respiratory Medicine, Royal Liverpool Hospital, Liverpool, United Kingdom.

Academic Primary Care, University of Aberdeen, Aberdeen, United Kingdom; Observational and Pragmatic Research Institute Pte Ltd, Singapore.

出版信息

J Allergy Clin Immunol Pract. 2017 Jul-Aug;5(4):1015-1024.e8. doi: 10.1016/j.jaip.2016.11.007. Epub 2016 Dec 22.

DOI:10.1016/j.jaip.2016.11.007
PMID:28017629
Abstract

BACKGROUND

Asthma attacks are common, serious, and costly. Individual factors associated with attacks, such as poor symptom control, are not robust predictors.

OBJECTIVE

We investigated whether the rich data available in UK electronic medical records could identify patients at risk of recurrent attacks.

METHODS

We analyzed anonymized, longitudinal medical records of 118,981 patients with actively treated asthma (ages 12-80 years) and 3 or more years of data. Potential risk factors during 1 baseline year were evaluated using univariable (simple) logistic regression for outcomes of 2 or more and 4 or more attacks during the following 2-year period. Predictors with significant univariable association (P < .05) were entered into multiple logistic regression analysis with backward stepwise selection of the model including all significant independent predictors. The predictive accuracy of the multivariable models was assessed.

RESULTS

Independent predictors associated with future attacks included baseline-year markers of attacks (acute oral corticosteroid courses, emergency visits), more frequent reliever use and health care utilization, worse lung function, current smoking, blood eosinophilia, rhinitis, nasal polyps, eczema, gastroesophageal reflux disease, obesity, older age, and being female. The number of oral corticosteroid courses had the strongest association. The final cross-validated models incorporated 19 and 16 risk factors for 2 or more and 4 or more attacks over 2 years, respectively, with areas under the curve of 0.785 (95% CI, 0.780-0.789) and 0.867 (95% CI, 0.860-0.873), respectively.

CONCLUSIONS

Routinely collected data could be used proactively via automated searches to identify individuals at risk of recurrent asthma attacks. Further research is needed to assess the impact of such knowledge on clinical prognosis.

摘要

背景

哮喘发作较为常见,且较为严重、花费较高。发作相关的个体因素,如症状控制不佳,不能很好地预测发作。

目的

我们研究英国电子病历中丰富的数据是否能识别出有复发性发作风险的患者。

方法

我们分析了 118981 例有积极治疗的哮喘(年龄 12-80 岁)且有 3 年以上数据的患者匿名、纵向的医疗记录。使用单变量(简单)逻辑回归分析在基线 1 年内的潜在危险因素,评估以下 2 年期间发生 2 次或以上及 4 次或以上发作的结局。单变量分析中与结果有显著关联(P<.05)的预测因子被纳入多变量逻辑回归分析,模型采用向后逐步选择,包括所有显著的独立预测因子。评估多变量模型的预测准确性。

结果

与未来发作相关的独立预测因子包括基线年发作的标志物(急性口服皮质类固醇疗程、急诊就诊)、更频繁地使用缓解药物和卫生保健资源、更差的肺功能、当前吸烟、血嗜酸性粒细胞增多、鼻炎、鼻息肉、湿疹、胃食管反流病、肥胖、年龄较大和女性。口服皮质类固醇疗程数与发作的关联最强。最终的交叉验证模型分别纳入了 19 个和 16 个 2 年期间发生 2 次或以上及 4 次或以上发作的风险因素,曲线下面积分别为 0.785(95%CI,0.780-0.789)和 0.867(95%CI,0.860-0.873)。

结论

可通过自动搜索,使用常规收集的数据积极识别有复发性哮喘发作风险的个体。需要进一步研究评估此类知识对临床预后的影响。

相似文献

1
Identifying Risk of Future Asthma Attacks Using UK Medical Record Data: A Respiratory Effectiveness Group Initiative.利用英国医疗记录数据识别未来哮喘发作的风险:呼吸有效性研究组的一项倡议。
J Allergy Clin Immunol Pract. 2017 Jul-Aug;5(4):1015-1024.e8. doi: 10.1016/j.jaip.2016.11.007. Epub 2016 Dec 22.
2
High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma.血液嗜酸性粒细胞计数高是成人持续性哮喘未来哮喘加重的一个危险因素。
J Allergy Clin Immunol Pract. 2014 Nov-Dec;2(6):741-50. doi: 10.1016/j.jaip.2014.06.005. Epub 2014 Aug 29.
3
Burden of Chronic Oral Corticosteroid Use by Adults with Persistent Asthma.慢性口服皮质类固醇治疗持续性哮喘成人的负担。
J Allergy Clin Immunol Pract. 2017 Jul-Aug;5(4):1050-1060.e9. doi: 10.1016/j.jaip.2016.12.023. Epub 2017 Feb 10.
4
Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.美国哮喘患者中既往医疗保健使用与吸入皮质类固醇和长效β2-肾上腺素能激动剂联合治疗起始的相关性。
Clin Ther. 2009 Nov;31(11):2574-83. doi: 10.1016/j.clinthera.2009.11.007.
5
Applying UK real-world primary care data to predict asthma attacks in 3776 well-characterised children: a retrospective cohort study.应用英国真实世界初级保健数据预测 3776 名特征明确儿童的哮喘发作:一项回顾性队列研究。
NPJ Prim Care Respir Med. 2018 Jul 23;28(1):28. doi: 10.1038/s41533-018-0095-5.
6
The association of obesity and asthma severity and control in children.儿童肥胖与哮喘严重程度和控制的关系。
J Allergy Clin Immunol. 2011 Nov;128(5):964-9. doi: 10.1016/j.jaci.2011.06.031. Epub 2011 Aug 6.
7
High use of health services in patients with suboptimal asthma drug regimens: a population-based assessment in British Columbia, Canada.在加拿大不列颠哥伦比亚省,药物治疗方案不充分的哮喘患者对卫生服务的高利用率:一项基于人群的评估。
Pharmacoepidemiol Drug Saf. 2013 Jul;22(7):744-51. doi: 10.1002/pds.3444. Epub 2013 Apr 5.
8
The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β-agonists in the United Kingdom: a cross-sectional analysis.英国接受吸入皮质类固醇加长效β激动剂治疗的哮喘患者中哮喘控制不佳的影响:一项横断面分析。
NPJ Prim Care Respir Med. 2017 Mar 9;27(1):17. doi: 10.1038/s41533-017-0014-1.
9
Cost and health care utilization in patients with asthma and high oral corticosteroid use.哮喘及高剂量口服糖皮质激素使用患者的费用与医疗保健利用情况
Ann Allergy Asthma Immunol. 2017 May;118(5):638-639. doi: 10.1016/j.anai.2017.02.023.
10
Risk factors for asthma attacks and poor control in children: a prospective observational study in UK primary care.儿童哮喘发作和控制不佳的危险因素:英国初级保健中前瞻性观察研究。
Arch Dis Child. 2022 Jan;107(1):26-31. doi: 10.1136/archdischild-2020-320110. Epub 2021 May 20.

引用本文的文献

1
Optimising stakeholder engagement during intervention planning and development using the Person-Based Approach: the example of an online FeNO-guided asthma management intervention in primary care.采用基于人的方法在干预计划和开发过程中优化利益相关者参与:以基层医疗中一项基于在线呼出气一氧化氮(FeNO)指导的哮喘管理干预为例。
NPJ Prim Care Respir Med. 2025 Jul 25;35(1):33. doi: 10.1038/s41533-025-00435-9.
2
Burden of Oral Corticosteroid Use in Severe Asthma: Challenges and Opportunities.重度哮喘患者口服糖皮质激素的使用负担:挑战与机遇
Allergy. 2025 Aug;80(8):2113-2127. doi: 10.1111/all.16569. Epub 2025 Jun 23.
3
Machine learning-based prediction of in-hospital mortality in patients with chronic respiratory disease exacerbations.
基于机器学习对慢性呼吸道疾病加重患者院内死亡率的预测
Digit Health. 2025 Apr 4;11:20552076251326703. doi: 10.1177/20552076251326703. eCollection 2025 Jan-Dec.
4
Promoting the implementation of clinical decision support systems in primary care: A qualitative exploration of implementing a Fractional exhaled Nitric Oxide (FeNO)-guided decision support system in asthma consultations.促进基层医疗中临床决策支持系统的实施:对在哮喘会诊中实施呼出气一氧化氮(FeNO)引导的决策支持系统的定性探索。
PLoS One. 2025 Feb 13;20(2):e0317613. doi: 10.1371/journal.pone.0317613. eCollection 2025.
5
Baseline Characteristics and Maintenance Therapy Choice on Symptom Control, Reliever Use, Exacerbation Risk in Moderate-Severe Asthma: A Clinical Modelling and Simulation Study.基线特征和维持治疗选择对中重度哮喘症状控制、缓解药物使用、加重风险的影响:一项临床建模和模拟研究。
Adv Ther. 2024 Nov;41(11):4065-4088. doi: 10.1007/s12325-024-02962-2. Epub 2024 Sep 6.
6
A Simulation Study of the Effect of Clinical Characteristics and Treatment Choice on Reliever Medication Use, Symptom Control and Exacerbation Risk in Moderate-Severe Asthma.一项关于临床特征和治疗选择对中重度哮喘缓解药物使用、症状控制和加重风险影响的模拟研究。
Adv Ther. 2024 Aug;41(8):3196-3216. doi: 10.1007/s12325-024-02914-w. Epub 2024 Jun 25.
7
Sex differences in asthma control, lung function and exacerbations: the ATLANTIS study.哮喘控制、肺功能和加重的性别差异:ATLANTIS 研究。
BMJ Open Respir Res. 2024 Jun 19;11(1):e002316. doi: 10.1136/bmjresp-2024-002316.
8
The Association Between Short-Acting β-Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia.短作用β激动剂处方过多与患者报告的哮喘控制和加重的获得和使用之间的关联:来自澳大利亚的数据。
Adv Ther. 2024 Mar;41(3):1262-1283. doi: 10.1007/s12325-023-02746-0. Epub 2024 Feb 4.
9
Effect of Individual Patient Characteristics and Treatment Choices on Reliever Medication Use in Moderate-Severe Asthma: A Poisson Analysis of Randomised Clinical Trials.个体患者特征和治疗选择对中重度哮喘缓解药物使用的影响:随机临床试验的泊松分析。
Adv Ther. 2024 Mar;41(3):1201-1225. doi: 10.1007/s12325-023-02774-w. Epub 2024 Feb 1.
10
Machine Learning Approaches to Predict Asthma Exacerbations: A Narrative Review.预测哮喘急性发作的机器学习方法:一篇叙述性综述。
Adv Ther. 2024 Feb;41(2):534-552. doi: 10.1007/s12325-023-02743-3. Epub 2023 Dec 19.